- All sections
- C - Chemistry; metallurgy
- C12N - Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media
- C12N 15/68 - Stabilisation of the vector
Patent holdings for IPC class C12N 15/68
Total number of patents in this class: 143
10-year publication summary
9
|
12
|
8
|
8
|
17
|
11
|
6
|
10
|
10
|
3
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Curevac SE | 235 |
10 |
BioNTech SE | 482 |
9 |
Curevac GmbH | 54 |
4 |
International AIDS Vaccine Initiative | 86 |
4 |
BlueAllele, LLC | 20 |
4 |
Massachusetts Institute of Technology | 9795 |
3 |
Case Western Reserve University | 1727 |
3 |
CureVac AG | 151 |
3 |
Ethris GmbH | 89 |
3 |
King Faisal Specialist Hospital and Research Centre | 10 |
3 |
National University of Singapore | 2228 |
3 |
Tron - Translationale Onkologie an der Universitatsmedizin der Johannes Gutenberg- Universitat Mainz gGmbH | 54 |
3 |
BASF SE | 19740 |
2 |
Ambrx, Inc. | 191 |
2 |
BioNTech AG | 79 |
2 |
BioNTech RNA Pharmaceuticals GmbH | 76 |
2 |
Fuso Pharmaceutical Industries, Ltd. | 136 |
2 |
National University Corporation Hokkaido University | 1323 |
2 |
TERRAMARK MARKENCREATION GmbH | 104 |
2 |
Tron-translationale Onkologie an der Universitatsmedizin der Johannes Gutenberg-universitat Mainz Gemeinnutzige GmbH | 172 |
2 |
Other owners | 75 |